期刊文献+

鮀滨-华明阿霉素联合方案治疗恶性肿瘤116例临床观察

REPORTING RESULTS OF TUOBIN-HUAMING ADRIAMYCIN COMBINATION REGIMEN IN 116 MALIGNANT TUMOUR TREATMENT
下载PDF
导出
摘要 本文应用鮀滨-华明阿霉素联合方案治疗常见恶性肿瘤116例,总有效率达45.7%.其中对恶性淋巴瘤的疗效最佳,有效率为92.3%,其次为乳腺癌,有效率为50%.其毒性反应主要有消化道反应,骨髓抑制和脱发,大多属Ⅰ~Ⅱ度.这说明鮀滨-华明阿霉素对恶性肿瘤有较好的疗效,毒性反应也较低. 116 cases of malignant tumour were treated with combination chemotherapy program of Tuobin-Huaming Adriamycin and the overall response rate (RR) was 45. 7%. The best result was seen in malignant lymphoma and the reponse rate was 92. 3%. The reponse rate of breast cancer was 50%. The major toxic side effects were gastro-intestinal tract, myelosuppres-sion and trichomadesis. But the great majority was limited to Ⅰ~Ⅱ grade. We have the view that Tuobin-Huaming Adriamycin have a good result in the malignant tumour treatment and the toxic side effects are mild.
出处 《蚌埠医学院学报》 CAS 1993年第4期246-247,共2页 Journal of Bengbu Medical College
关键词 阿霉素 淋巴瘤 乳腺癌 合并用药 Tuobin-Huaming Adriamycin malignant lymphoma breast cancer combination regimen
  • 相关文献

参考文献4

共引文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部